Company intelligence / Profile preview

Pedal

Ownership: Private
Development stage: Other

Overview

Pedal is an AI-native lab automation and scientific software company building an autonomous lab platform for life sciences research. The company positions its product as an intelligent system embedded across experimental workflows, designed to learn from experiments, recommend next steps, adapt to laboratory needs, and accelerate iterative discovery. Based on the available public information, Pedal appears to focus on enabling research operations and experimentation rather than developing its own disclosed therapeutic pipeline. Its public materials emphasize scientific discovery, automation, and the intersection of AI with the life sciences.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Pedal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pedal.

Explore the full profile